 | Up a level |
Merola, Joseph F; Chiou, Albert S; During, Emmanuel; Costanzo, Antonio; Foley, Peter; Alfalasi, Amani; Gogate, Shaila; Pinter, Andreas; Dodiuk-Gad, Roni; Simon, Dagmar; Tauber, Marie; Weller, Richard; Pereyra-Rodriguez, Jose-Juan; Ardeleanu, Marius; Wu, Jiangming; Ozturk, Zafer E (2023). Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study. The British journal of dermatology, 189(6), pp. 685-694. Wiley 10.1093/bjd/ljad284
Gisondi, Paolo; Piaserico, Stefano; Naldi, Luigi; Dapavo, Paolo; Conti, Andrea; Malagoli, Piergiorgio; Marzano, Angelo Valerio; Bardazzi, Federico; Gasperini, Massimo; Cazzaniga, Simone; Costanzo, Antonio (2021). Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience. Journal of allergy and clinical immunology, 147(2), 558-560.e1. Elsevier 10.1016/j.jaci.2020.10.032
Lande, Roberto; Botti, Elisabetta; Jandus, Camilla; Dojcinovic, Danijel; Fanelli, Giorgia; Conrad, Curdin; Chamilos, Georgios; Feldmeyer, Laurence; Marinari, Barbara; Chon, Susan; Vence, Luis; Riccieri, Valeria; Guillaume, Phillippe; Navarini, Alex A; Romero, Pedro; Costanzo, Antonio; Piccolella, Enza; Gilliet, Michel; Frasca, Loredana (2015). Corrigendum: the antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. Nature communications, 6, p. 6595. Nature Publishing Group 10.1038/ncomms7595
